出版物
Cannabis’ legalization and what it means for regulatory regimes worldwide
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Global | 出版物 | 十月 2020
Our global Food and Agribusiness team has a deep understanding of the existing and emerging issues surrounding the global cannabis industry. Cannabis is a sector in a state of rapid transition globally, as numerous countries and states have legalized its use for either recreational or medicinal purposes in recent years. This creates a myriad of opportunities and challenges for companies considering investment in the sector, particularly in relation to investments across multiple jurisdictions. Find out what’s new in this developing industry sector.
出版物
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
出版物
The maturation of the cannabis sector is presenting an array of opportunities to private producers and retailers.
出版物
In the 12 months leading to legalization in October 2018, Canadian public companies already in the medical cannabis space experienced “jaw-dropping growth” in their market capitalizations, notwithstanding that many reported negative earnings.
出版物
The cannabis sector is a growing and exciting sector.
出版物
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
出版物
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
出版物
On 8 September 2024, the Ministry of Commerce (MOFCOM), the National Health Commission (NHC) and the National Medical Products Administration jointly released the Notice on Carrying Out Pilot Programs to Expand the Opening-up in the Healthcare Sector (关于在医疗领域开展扩大开放试点工作的通知) (the Notice) .
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023